Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Caplin Point Laboratories Ltd.
NSE: CAPLIPOINT
|
BSE: 524742
|
ISIN: INE475E01026
|
Industry: Pharmaceuticals
Revenue Guidance
|
Mid-range Performer
1916.9000
19.10
(
1.01
%)
NSE
Dec 18, 2025
11:41 AM
27.42% Fall from 52W High
Volume:
14,683
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Caplin Point Laboratories Ltd.
06 Aug 2022
Revenue Guidance
1916.90
1.01%
Caplin Point Laboratories
Buy:
Caplin Point Laboratories ...
by
ICICI Direct
Target: 1000
Target
ICICI Direct
Caplin Point Laboratories Ltd. is trading below all available SMAs
More from Caplin Point Laboratories Ltd.
Recommended
Market trades higher, Bhavish Aggarwal sells shares worth Rs 142 cr in Ola Electric
Trendlyne Marketwatch |
18 Dec 2025, 11:26AM
Are Indian consumers running out of choices?
The Baseline |
17 Dec 2025, 06:13PM
Caplin Point Laboratories maintains export momentum, expands ambitions to new markets
|
01 Jul 2022